About
Joe Betts-LaCroix is the Co-founder and CEO of Retro Biosciences, a longevity biotech company backed by Sam Altman that raised $1 billion in January 2025 and is pursuing first-in-human clinical trials to extend healthy human lifespan by ten years. He is a serial entrepreneur (co-founded OQO, HealthTap) with MIT and Harvard credentials, a Part-time Partner at Y Combinator, and an active angel investor in longevity and biotech startups. He previously advised Recursion and worked at Halcyon Molecular (backed by Thiel's Founders Fund).
Areas of interest
longevityaging biologyhealthspan extensionbiotechAI in biologydigital healthdecentralized science (DeSci)blockchain/crypto (via DeSci)enterprise applicationshardware/deep tech